a coronary drug trial is that we've got the demand for it
written into the Senate report at least three .
Fortunately he's going to retire in August. I can't wait for
whoever is his successor. Anybody will be better.

Q:

You've kind of reached a plateau. What is your prediction in
the field of medical research?

Mrs. Lasker:

Well, I think that we may very well have some
interesting breaks in drugs, both in cancer and in arteriosclerosis,
with such money as we now have, if they money's well used. No
matter how much money you have, if people have important drugs and
they can't get them tested, you aren't going to know it
So it becomes a struggle to get drugs that look important
tested adequately, It's also a struggle to get anti- hypertensive
drugs, which are well known, used on a wide scale.

Lots of doctors don't energetically recommend them to people
that do have high blood pressure. About 40 percent of the
people have high blood pressure don't know they have it.
So we need a big public health campaign to detect people who
are victims of high blood pressure, to use the
drugs that we now know work.